The federal government's funding cutbacks and NIH and other departments are anticipated to hit early stage companies the hardest. This is creating new opportunities for companies and alternative funding sources to fill the gap.
Check out this compelling discussion on early-stage life science trends led by a group of investors. This webinar, sponsored by fintech business Mercury, focuses on how they are advising startups, the developments they are seeing, from emerging tech trends, the role of accelerators, the impact of AI, and their outlook.
No comments